Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Hematology-Oncology

Bloomberg News reports that the FDA has issued a report on Sanofi‘s multiple sclerosis drug, Lemtrada, warning of its fatal symptoms. Lemtrada was approved earlier this year in Europe and “was at the center of Paris-based Sanofi’s $20...
About 15,680 Americans will be diagnosed with chronic lymphocytic leukemia (CLL) and about 4,580 will die from it this year, but now Roche‘s Gazyva shows promise as a potential new treatment, Bloomberg News reports. Compared to patients taking...
Sales of Ariad Pharmaceutical‘s Iclusig for treatment of chronic myeloid leukemia have come to a halt after the FDA issued a statement reporting on adverse vascular events associated with the drug, The New York Times reports. The drug was approved...